Your browser doesn't support javascript.
loading
No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study.
Prosperini, Luca; Annovazzi, Pietro; Boffa, Laura; Buscarinu, Maria Chiara; Gallo, Antonio; Matta, Manuela; Moiola, Lucia; Musu, Luigina; Perini, Paola; Avolio, Carlo; Barcella, Valeria; Bianco, Assunta; Farina, Deborah; Ferraro, Elisabetta; Pontecorvo, Simona; Granella, Franco; Grimaldi, Luigi M E; Laroni, Alice; Lus, Giacomo; Patti, Francesco; Pucci, Eugenio; Pasca, Matteo; Sarchielli, Paola.
Afiliação
  • Prosperini L; Department of Neurosciences, S. Camillo-Forlanini Hospital, C.ne Gianicolense 87, 00152, Rome, Italy. luca.prosperini@gmail.com.
  • Annovazzi P; MS Centre, S. Antonio Abate Hospital, Gallarate, VA, Italy.
  • Boffa L; Department of Neurosciences, MS Center, Tor Vergata University, Rome, Italy.
  • Buscarinu MC; Department of Neurosciences, Mental Health and Sensory Organs, Sapienza University, S. Andrea Hospital, Rome, Italy.
  • Gallo A; Department of Medical, Surgical, Neurological, Metabolic and Aging Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy.
  • Matta M; Regional MS Centre, S. Luigi Gonzaga Hospital, Orbassano, TO, Italy.
  • Moiola L; Department of Neurology, Institute of Experimental Neurology, Division of Neuroscience, S. Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.
  • Musu L; MS Center, Binaghi Hospital, ASSL Cagliari, ATS regione Sardegna, Cagliari, Italy.
  • Perini P; Department of Neurosciences, MS Centre, University Hospital, Padua, Italy.
  • Avolio C; Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.
  • Barcella V; MS Center, ASST Papa Giovanni XXIII, Bergamo, MI, Italy.
  • Bianco A; Fondazione Policlinico A. Gemelli, IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.
  • Farina D; Department of Neuroscience and Imaging, University "G. d'Annunzio", Chieti, Italy.
  • Ferraro E; Neurology Unit, S. Filippo Neri Hospital, Rome, Italy.
  • Pontecorvo S; Department of Neurology and Psychiatry, Sapienza University, Rome, Italy.
  • Granella F; Department of Medicine and Surgery, University of Parma, Parma, Italy.
  • Grimaldi LME; U.O.C. Neurologia, Fondazione Istituto "G.Giglio, Cefalù, PA, Italy.
  • Laroni A; Department of Neurology, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI) and Center of Excellence for Biomedical Research (CEBR), University of Genoa, Genoa, Italy.
  • Lus G; Departement of Neurosciences, IRCCS Osp. Policlinico S. Martino, Genoa, Italy.
  • Patti F; Department of Medical, Surgical, Neurological, Metabolic and Aging Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy.
  • Pucci E; Department of Medical and Surgical Sciences and Advanced Technologies, Neuroscience Section, University of Catania, Catania, Italy.
  • Pasca M; UOC Neurologia Ospedale "A. Murri", ASUR Marche - AV4, Fermo, Italy.
  • Sarchielli P; Department of Neurofarba, University of Florence, Florence, Italy.
J Neurol ; 265(12): 2851-2860, 2018 Dec.
Article em En | MEDLINE | ID: mdl-30259178
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Esclerose Múltipla Recidivante-Remitente / Alemtuzumab / Fatores Imunológicos Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Revista: J Neurol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Itália
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Esclerose Múltipla Recidivante-Remitente / Alemtuzumab / Fatores Imunológicos Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Revista: J Neurol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Itália